Literature DB >> 557462

In vitro propagation of prostate adenocarcinoma cells from rats.

C F Chang, M Pollard.   

Abstract

Two rat adenocarcinomas were physically dispersed and propagated in vitro. Epithelial and fibroblast cell lines were cloned from them and the monolayer cell lines derived therof were further characterized. The cells produced acid phosphatase in early in vitro cell passages, and later they turned negative. Fibroblast-like cells produced no tumors when implanted in syngeneic Lobund Wistar rats, but as few as 10 epithelial cells produced metastasizing adenocarcinomas in them. A third prostate tumor has yielded a line of epithelial cells which reproduced the original tumor type in inoculated rats, but the cells have not yet been characterized. Rat prostate adenocarcinomas provided a useful model system for in vitro and in vivo studies on prostate cancer and on metatasis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 557462

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


  4 in total

1.  Androgen receptor expression in primary prostate cancers of Lobund-Wistar rats and in tumor-derived cell lines.

Authors:  J M Bentel; M A Pickering; M Pollard; J A Clements; W D Tilley
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

2.  Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.

Authors:  Malgorzata Kamocka; Morris Pollard; Mark Suckow; Wojciech P Mielicki; Elliot D Rosen
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

3.  Characterization of a very-low-density lipoprotein (VLDL)-associated cytotoxic factor.

Authors:  S Y Chan; M Pollard
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

4.  Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.

Authors:  Michael Schlicht; Brian Matysiak; Tracy Brodzeller; Xinyu Wen; Hang Liu; Guohui Zhou; Rajiv Dhir; Martin J Hessner; Peter Tonellato; Mark Suckow; Morris Pollard; Milton W Datta
Journal:  BMC Genomics       Date:  2004-08-20       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.